Summary of significant treatment × time effect. حسب Wensheng Xiao (16557866)

Summary of significant single-arm time effect. حسب Wensheng Xiao (16557866)

Distribution of continuous variables of all 3 visits of group 1 (placebo) and group 2 (placebo) that have no significant difference among the groups. حسب Nattapon Riengvirodkij (11268720)

الموضوعات:

Study selection criteria. حسب Filip Stanicic (17808254)

الموضوعات:

PICOS criteria for the SLR. حسب Filip Stanicic (17808254)

الموضوعات:

PRISMA flow chart. حسب Filip Stanicic (17808254)

الموضوعات:

Brain regions with significantly decreased activations for the Raven task are shown in blue. حسب Morteza Fattahi (15892028)

Characteristics of census tracts that are projected to have high (groups: 250-399 and 400+) and low (groups: 50-99 and 100-249) MHC utilization for COVID-19 vaccination before Marc... حسب Fatih Gezer (21485468)

Transepithelial resistance of NHBE decreases significantly after PAA exposure. حسب Ellie S. Burns (21246537)

Test soil parameters. حسب Yonggang Huang (223155)

الموضوعات:

Influence of UHMWPE length on swelling pressure. حسب Yonggang Huang (223155)

الموضوعات:

UHMWPF parameters. حسب Yonggang Huang (223155)

الموضوعات:

Influence of UHMWPE content on swelling pressure. حسب Yonggang Huang (223155)

الموضوعات:

Soil partice-size distribution. حسب Yonggang Huang (223155)

الموضوعات:

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Primary and secondary efficacy end points (intention-to-treat population). حسب Benjamin R. Lewis (22279166)

الموضوعات:

Demographic and clinical characteristics of participants at baseline. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study-related adverse events. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study flow chart. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات: